Education
About Us
Working with TipRanks
Follow Us
IDEAYA Biosciences (IDYA)
NASDAQ:IDYA
Darovasertib, Primary Local Therapy
Uveal Melanoma
Phase III
Not Yet Recruiting
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Jun 03, 2025
―
Gsk4418959, Pd-1 Inhibitor
Solid Tumor, Endometrial Cancer, Rectal Cancer, Colon Cancer, Neoplasms, Colorectal
Phase I/II
Recruiting
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
Nov 26, 2024
―
Darovasertib
Uveal Melanoma
Phase II
Recruiting
(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma
Jun 06, 2023
―
Pembrolizumab, Ide-161
Colorectal Cancer, Endometrial Cancer, Ovarian Cancer, Breast Cancer, Prostate Cancer, Nsclc, Head And Neck Cancers, Advanced Or Metastatic Solid Tumors
Phase I
Recruiting
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Mar 17, 2023
―
Sacituzumab Govitecan, Paclitaxel, Docetaxel, Ide397
Solid Tumor
Phase I
Recruiting
Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion
Mar 09, 2021
―
Ide196, Binimetinib, Crizotinib
Colorectal Cancer, Metastatic Uveal Melanoma, Other Solid Tumors, Cutaneous Melanoma
Phase I/II
Recruiting
Study of IDE196 in Patients with Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
May 09, 2019
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does IDEAYA Biosciences (IDYA) have in its pipeline
IDYA is currently developing the following drugs: Darovasertib, Primary Local Therapy, Gsk4418959, Pd-1 Inhibitor, Pembrolizumab, Nivolumab, Ipilimumab, Dacarbazine, Ide196, Crizotinib. These drug candidates are in various stages of clinical development as the company works toward FDA approval.